Mellado-Orellana R, Ortega-Chavarría MJ, Guerrero-Girón A, Díaz-Greene EJ, Rodríguez-Weber FL

Language: Spanish
References: 11
Page: 110-115
PDF size: 342.24 Kb.

ABSTRACT

Procalcitonin has been the subject of research for more than 10 years for discriminating bacterial infections from non-bacterial infections and showing benefits in antibiotic administration protocols, even in the pediatric population. Even when procalcitonin does not interfere with the initial antimicrobial management in a patient with a high suspicion of infection, its determination may influence the duration of treatment. Likewise, the identification of the cause in a timely manner is decisive so as not to delay the indicated treatment or to avoid prolonging unnecessary therapies.

REFERENCES

1. Choi JJ, McCarthy MWl. Novel applications for serum procalcitonin testing in clinical practice. Expert Rev Mol Diagn 2018; 0 (0). doi. 10.1080/14737159. 2018.1407244.

2. Schuetz P, Wirz Y, Sager R, Christ-Crain M, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 2018; 95-107. doi. 10.1016/S1473- 3099(17)30592-3.

3. Montassier E, Javaudin F, Moustafa F, Nandjou D. Guideline-based clinical assessment versus procalcitonin- guided antibiotic use in pneumonia: a pragmatic randomized trial. 2019: 1-12. doi. 10.1016/j.annemergmed. 2019.02.025.

4. Schuetz P, Bretscher C, Bernasconi L, Mueller B. Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis. Expert Rev Mol Diagn 2017; 0 (0). doi. 10.1080/14737159.2017.1324299.

5. Huang DT, Yealy DM, Filbin MR, Brown AM, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. 2018; 379: 236-249. doi. 10.1056/ NEJMoa1802670.

6. Bassetti M, Russo A, Righi E, Dolso E, et al. Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology infection etiology. Expert Rev Anti Infect Ther 2019; 00 (00): 1-7. doi. 10.1080/14787210.2019.1562335.

7. Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med 2017: 1-11. doi. 10.1186/s12916-017-0795-7.

8. Vijayan AL, Vanimaya, Ravindran S, Saikant R, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. 2017: 1-7. doi. 10.1186/s40560-017-0246-8.

9. Schuetz P, Bolliger R, Merker M, Christ-Crain M, et al. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Expert Rev Anti Infect Ther 2018; 16 (7): 555-564. doi. 10.1080/14787210.2018.1496331.

10. King LM, Fleming-Dutra KE, Hicks LA. Advances in optimizing the prescription of antibiotics in outpatient settings. 2018. doi. 10.1136/bmj.k3047.

11. Rhodes A, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017. doi. 10.1097/CCM.0000000000002255.